Attending BioFIT 2025 in Strasbourg

🌟We’re getting ready for BioFIT 2025 !

We’re delighted to announce CURLIM’s participation in BioFIT 2025, taking place in Strasbourg on December 2–3. 

And we are also proud to share that we have been selected to pitch in the “Rare Diseases” category of the BioFIT Start-up Slams.

BioFIT is a key meeting point in Europe for investors seeking high-potential biotech startups and academic spin-offs. 

Being selected for the Start-up Slams is an opportunity to highlight CLM001, our innovative nanomedicine developed for peripheral neuropathies such as Charcot-Marie-Tooth disease (CMT), and to present our vision and development strategy to potential partners.

If you are attending BioFIT, we would be pleased to arrange a meeting.
💬 Contact us to schedule a one-to-one meeting.